Hong Kong Med J 2007;13(Suppl 5):S18-22
Prevention of ulcer bleeding in high-risk patients: is the enthusiasm for COX-2 selective NSAIDs justified?
FK Chan, LC Hung, BY Suen, JC Wu, KC Lee, VK Leung, AJ Hui, KF To, WK Leung, VW Wong, SC Chung, JJ Sung
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong
Among patients with previous ulcer bleeding, celecoxib is comparable to the combination of diclofenac plus omeprazole for the prevention of recurrent bleeding.